FT Vest U.S. Equity Max Buffer ETF - AugustAUGM

The FT Vest U.S. Equity Max Buffer ETF (AUGM) launched as a one-year buffered play on the S&P 500, promising capped upside and a 15% loss buffer before investors feel a thing-except the 0.85% annual management fee that starts the moment the trade settles. The fund’s Nasdaq profile confirms it trades daily on a major exchange, but the page offers no insight into how the buffer behaves when the index gap-locks lower on an earnings Friday or during a liquidity event. That makes Nasdaq’s real-time quote more useful than its marketing section, which is par for the course for wrapped products that outsource the actual equity exposure to derivatives desks and keep the retail wrapper shiny.

The fund’s SEC EDGAR entry shows it is a registered investment company under the Investment Company Act of 1940, uses options and swaps to deliver the buffered outcome, and discloses the 0.85% expense ratio without apology. There is no embedded performance figure in the filing-merely the mechanism: the fund targets 15% downside protection over a one-year “buffer period,” with upside capped at a predetermined multiple of the S&P 500’s return, all else being equal. The EDGAR filing proves the wrapper exists, the mandate is stated, and the fee is explicit, but it does not prove how the options overlay will behave when implied volatility spikes, bid-ask widen, or the index gaps across a strike on an options expiry. That uncertainty sits in the fine print; the Nasdaq page merely lists the ticker and the last trade.

The FINRA Fund Analyzer confirms the 0.85% expense ratio and flags that the fund’s tracking may deviate materially from the S&P 500 due to the embedded options strategy, the annual reset mechanics, and the costs of maintaining the buffer. The analyzer does not quantify the tracking error or the realised cost of the options overlay-it merely warns that the fund’s returns can diverge from the index. In practice, that means investors are paying for the privilege of owning a structure that promises less pain but delivers less control and a fee that compounds whether the buffer works or not.

For readers who like hard numbers, none are supplied in the evidence rail used here: no AUM, no daily volume, no options cost breakdown, no tracking error history, and no comparative performance versus the S&P 500. The Nasdaq page shows the ticker is live, the SEC confirms the legal wrapper, and FINRA confirms the expense ratio and the presence of tracking risk, but the file does not contain the data points that would let an investor size the trade beyond the stated mandate and the fee. Until those figures are disclosed or sourced independently, AUGM remains a priced promise with an unquantified tracking gap.